CAS No. |
103974-46-5 |
|---|---|
中文名称 |
(2S,5S,8S,11S,17S,20S,23S)-23-氨基-11-[(1H-吲哚-3-基)甲基]-2-苄基-5-(羧甲基)-20-(4-羟基苄基)-8,17-双[2-(甲硫基)乙基]-4,7,10,13,16,19,22-七氧代-3,6,9,12,15,18,21-七氮杂二十五烷二酸 |
英文名称 |
(2S,5S,8S,11S,17S,20S,23S)-11-((1H-indol-3-yl)methyl)-23-amino-2-benzyl-5-(carboxymethyl)-20-(4-hydroxybenzyl)-8,17-bis(2-(methylthio)ethyl)-4,7,10,13,16,19,22-heptaoxo-3,6,9,12,15,18,21-heptaazapentacosanedioic acid |
别名 |
Cholecystokinin Octapeptide free acid (desulfated),Sincalide (free acid) (desulfated);Cholecystokinin Octapeptide free acid (desulfated) H-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-OH;L-Phenylalanine, L-α-aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-α-aspartyl-;cholecystokinin octapeptide(human);CCK (26-33) free acid |
标准英文名 |
(2S,5S,8S,11S,17S,20S,23S)-11-((1H-indol-3-yl)methyl)-23-amino-2-benzyl-5-(carboxymethyl)-20-(4-hydroxybenzyl)-8,17-bis(2-(methylthio)ethyl)-4,7,10,13,16,19,22-heptaoxo-3,6,9,12,15,18,21-heptaazapentacosanedioic acid |
MDL No. |
MFCD00076489 |
分子式 |
C49H61N9O14S2 |
分子量 |
1064.21 |
精确分子量 |
1063.38 |
SMILES |
CSCC[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O |
标准SMILES |
CSCC[C@H](NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC1C=CC(O)=CC=1)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1C=CC=CC=1)C(O)=O |
用途 |
Reduces food intake and induces gallbladder contraction. |
InChIKey |
PUZFEBZBSNCBNS-YRVFCXMDSA-N |
|
|
评论 |
|---|